Looks like NITE, CANT, & ETRF did nothing but drive up the price and they are trying to buy back at 0.17.
Has anyone been able to find out who owns the Novalere rights? It looks like the FDA approval will be for the manufacturing site and not Innovus. But what about the rights?
I was initially under the assumption Innovus would get the approval but that doesn't look like the case. From what I've been reading on the sites, it looks like IR is quiet on this matter. They haven't been able to get clarification on the last 8k.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.